5-甲基-7-甲氧基异黄酮 | 82517-12-2

• 物质功能分类: 生物化工 - 提取物
• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 中文名称: 5-甲基-7-甲氧基异黄酮
• 中文别名: 异黄酮；供应野生老鹳草提取物；异氧黄酮
• 英文名称: 5-methyl-7-methoxyisoflavone
• 英文别名: 7-methoxy-5-methyl-3-phenylchromen-4-one
• CAS: 82517-12-2
• 化学式: C₁₇H₁₄O₃
• mdl: MFCD03093036
• 分子量: 266.296
• InChiKey: WGOUYULOZZRTFS-UHFFFAOYSA-N

物化性质

• 熔点：
  116-120 °C
• 沸点：
  349.5°C (rough estimate)
• 密度：
  1.2327 (rough estimate)
• 溶解度：
  可溶于氯仿（轻微）、甲醇（轻微、超声处理）
• LogP：
  4.242 (est)
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.117
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2932999099
• 安全说明：
  S24/25
• 储存条件：
  存于阴凉干燥处。

SDS

Name:	5-Methyl-7-methoxyisoflavone 98% Material Safety Data Sheet
Synonym:	None Known
CAS:	82517-12-2

Section 1 - Chemical Product MSDS Name:5-Methyl-7-methoxyisoflavone 98% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
82517-12-2	5-Methyl-7-methoxyisoflavone	98%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. May be harmful if inhaled.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 82517-12-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C17H14O3
Molecular Weight: 266.3

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides, acid anhydrides, carbon dioxide.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 82517-12-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Methyl-7-methoxyisoflavone - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 82517-12-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 82517-12-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 82517-12-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

生物活性方面，5-Methyl-7-methoxyisoflavone 是一种非甾体合成代谢异黄酮。它能够增加肌肉质量和耐力。

在化学性质上，该物质为白色结晶粉末，可溶于甲醇、乙醇和 DMSO 等有机溶剂，来源于老鹳草和沙参根茎。

用途方面，5-Methyl-7-methoxyisoflavone 用作医药中间体。

反应信息

• 作为反应物：
  描述：

  5-甲基-7-甲氧基异黄酮 在 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 生成 1-(2-hydroxy-4-methoxy-6-methylphenyl)-2-phenylethan-1-one
  参考文献：
  名称：

  通过TsOH介导的串联反应合成7-羟基-6H-萘并[2,3-c]香豆素。

  摘要：

  已经开发出使用可用的1-（2-羟基苯基）-2-苯基乙酮和Meldrum酸合成7-羟基-6 H-萘[2,3- c ]香豆素的简洁有效的方法。这种转化涉及串联的羟醛反应/内酯化/弗里德-克来福特反应，形成内酯环和苯环。以水和丙酮为副产物显示出高原子经济性。机理研究证明了Meldrum酸的两个作用：（i）作为串联反应的试剂，以及（ii）作为Friedel-Crafts反应的催化剂。此外，7-羟基-6 H-萘[2,3- c]香豆素进一步通过芳基乙炔基，芳基，和氰基基团，得到d-π-A的化合物具有优良的荧光发射（有效地官能化Φ ˚F = 0.14-0.78）。

  DOI：

  10.1039/d0cc04452k
• 作为产物：
  描述：

  3,5-二甲氧基甲苯 在 哌啶 、 吡啶 、 三氯化铝 作用下， 生成 5-甲基-7-甲氧基异黄酮
  参考文献：
  名称：

  具有尿酸尿酸活性的芳氧基乙酸利尿剂。二。取代了[（4-氧代-4H-1-苯并吡喃-7-基）氧基]乙酸和相关化合物。

  摘要：

  二和三取代的[（4-氧代-4H-1-苯并吡喃-7-基）氧基]乙酸和4-氧代-3-苯基-4H-呋喃[2,3-h]-[1]合成了苯并吡喃-8-羧酸，并测试了其利尿钠和尿尿排尿活性。在测试的化合物中，3,5-二取代的[（4-oxo-4H-1-苯并吡喃-7-基）氧基]乙酸（6c-f，h，n和x）显示出有效的利钠尿和尿尿尿酸活性，而4 -氧代-3-苯基-4H-呋喃[2,3-h] [1]苯并吡喃-8-羧酸（6dd）仅具有强大的利尿活性。还讨论了结构-活性关系。

  DOI：

  10.1248/cpb.39.2681

文献信息

• One-step synthesis of 5,6-diaryl pyridine-2(1H)-thiones from isoflavones
  作者：Juanjuan Wang、Zunting Zhang、Wenli Wang、Fangfang Liu

  DOI：10.1039/c3ob27247h

  日期：——

  The one-step cyclocondensation of substituted isoflavones with cyanothioacetamide in the presence of sodium hydroxide gave an array of 3-cyano-5,6-diaryl pyridine-2(1H)-thiones in good yields. The procedure involves base-mediated ring opening of the isoflavones and subsequent Knoevenagel condensation between the 1,3-dicarbonyl intermediate generated from the isoflavones and cyanothioacetamide, followed

  取代异黄酮与 氰基硫代乙酰胺 在......的存在下 氢氧化钠以良好的收率得到了3-氰基-5,6-二芳基吡啶-2（1 H）-硫酮的阵列。该方法包括异黄酮的碱介导的开环，以及随后由异黄酮生成的1,3-二羰基中间体与Knoevenagel缩合。氰基硫代乙酰胺，然后进行闭环和脱水。
• Microwave Irradiation for Accelerating Synthesis of Diarylimidizo[1,5-a]pyrimidine Based on Isoflavones
  作者：Zunting Zhang、Pengfei Zhang、Taoying Kang、Mulin Zhu

  DOI：10.1002/cjoc.201100405

  日期：2012.4

  Microwave irradiation was used to accelerate the cyclocondensation of isoflavones and 5‐amino‐1H‐imidazole‐4‐carboxamide in the presence of sodium hydroxide to produce 3,4‐diphenyl‐imidazo[1,5‐a]pyrimidines in good to moderate yields.

  在氢氧化钠存在下，微波辐射用于加速异黄酮和5-氨基-1 H-咪唑-4-羧酰胺的环缩合反应，生成3,4-二苯基-咪唑并[1,5- a ]嘧啶，好到中等产量。
• Concise Synthesis of 2, 3-Diarylpyrimido[1,2-<i>a</i>]benzimidazole Based on Isoflavones
  作者：Zun-Ting Zhang、Li Qiu、Dong Xue、Jing Wu、Fei-Fei Xu

  DOI：10.1021/cc900064q

  日期：2010.3.8

  The 2,3-diarylpyrimido[1,2-a]benzimidazole derivatives were prepared by one-step cyclocondensation of 2-aminobenzimidazole with isoflavone in methanol. Single-crystal diffraction analysis was performed for 2-(2-hydroxyl-4-isopropoxy-phenyl)-3-phenylpyrimido[1,2-a]benzimidazole. The fluorescence properties of the fused 2, 3-diarylpyrimido[1, 2-a]benzimidazole were evaluated.

  通过2-氨基苯并咪唑与异黄酮在甲醇中的一步缩合反应来制备2,3-二芳基嘧啶并[1,2- a ]苯并咪唑衍生物。对2-（2-羟基-4-异丙氧基-苯基）-3-苯基嘧啶基[1,2- a ]苯并咪唑进行了单晶衍射分析。评价了熔融的2，3-二芳基嘧啶[1，2-a]苯并咪唑的荧光性质。
• Facile Synthesis of Diarylpyrazolo[1,5-<i>a</i>]pyrimidine from Isoflavones
  作者：Junling Yang、Zunting Zhang、Qing He

  DOI：10.1002/jhet.1633

  日期：2014.1

  A new facile and straightforward method for synthesis of 2-methyl-6,7-diphenyl- pyrazolo[1,5-a]pyrimidines has been described. The cyclocondensation of isoflavones with 3-amino-5-methylpyrazole in the presence of sodium methoxide gave fused 2-methyl-6,7-diphenylpyrazolo[1,5-a]pyrimidines in moderate to good yields. A series of 20 new compounds were obtained and characterized by FT-IR, NMR, and elemental

  已经描述了一种合成2-甲基-6,7-二苯基-吡唑并[1,5- a ]嘧啶的简便易行的新方法。在甲醇钠存在下，异黄酮与3-氨基-5-甲基吡唑的环缩合反应以中等至良好的产率得到了稠合的2-甲基-6,7-二苯基吡唑并[1,5- a ]嘧啶。获得了一系列20种新化合物，并通过FT-IR，NMR和元素分析对其进行了表征。
• Synthesis, crystal structure, characterization and antifungal activity of 3,4-diaryl-1H-Pyrazoles derivatives
  作者：Jin Zhang、Da-Jin Tan、Tao Wang、Si-Si Jing、Yang Kang、Zun-Ting Zhang

  DOI：10.1016/j.molstruc.2017.07.106

  日期：2017.12

  Abstract A series of 3,4-diaryl- 1H -pyrazoles derivatives were designed and synthesized by the reaction of 3-heteroarylchromones and 3-phenylchromones with hydrazine hydrate in good yields. All of those compounds were characterized by 1 H NMR, 13 C NMR, IR, and HRMS. Moreover, 3-(2,4-dihydroxyphenyl)-4-(4-hydroxyphenyl)- 1H -pyrazole and 3-(2,4-dihydroxy phenyl)-4-(4-methoxyphenyl)- 1H -pyrazole were

  摘要 通过3-杂芳基色酮和3-苯基色酮与水合肼反应，设计并合成了一系列3,4-二芳基-1H-吡唑衍生物。所有这些化合物均通过 1 H NMR、13 C NMR、IR 和 HRMS 进行表征。此外，3-(2,4-二羟基苯基)-4-(4-羟基苯基)-1H-吡唑和3-(2,4-二羟基苯基)-4-(4-甲氧基苯基)-1H-吡唑进一步符合以下条件单晶 X 射线衍射。此外，还评估了 3,4-二芳基-1H-吡唑对五种植物病原真菌（Cytospora sp.、Colletotrichum gloeosporioides、Botrytis cinerea、Alternaria solani 和 Fusarium solani）的抗真菌活性。3-(2-Hydroxy-4-isopropoxyphenyl)-4-phenyl-1H-pyrazole对Cytospora sp., C. gloeosporioides